Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Frontiers in Immunology|November 30, 2023
Arachidonate 15-lipoxygenase-mediated production of Resolvin D5n-3 DPA abrogates pancreatic stellate cell-induced cancer cell invasionGabriel A Aguirre, Michelle R Goulart, , et al.Reviews of Physiology, Biochemistry and Pharmacology|January 3, 2018
Insulin-Like Growth Factor 1 in the Cardiovascular SystemGabriel A Aguirre, José Luis González-Guerra, Luis Espinosa, et al.Journal of Translational Medicine|February 13, 2020
Is insulin-like growth factor-1 involved in Parkinson's disease development?Inma Castilla-Cortázar, Gabriel A Aguirre, Giovana Femat-Roldán, et al.Frontiers in Immunology|February 9, 2024
Corrigendum: Arachidonate 15-lipoxygenase-mediated production of Resolvin D5n-3 DPA abrogates pancreatic stellate cell-induced cancer cell invasionGabriel A Aguirre, Michelle R Goulart, Barts Pancreas Tissue Bank, et al.American Journal of Medical Genetics. Part A|November 19, 2016
Clinical and molecular diagnosis of a cartilage-hair hypoplasia with IGF-1 deficiencyInma Castilla-Cortázar, Julieta Rodríguez De Ita, Irene Martín-Estal, et al.Journal of Translational Medicine|May 6, 2017
Experimental approach to IGF-1 therapy in CCl4-induced acute liver damage in healthy controls and mice with partial IGF-1 deficiencyLuis A Morales-Garza, Juan E Puche, Gabriel A Aguirre, et al.Clinical Case Reports|November 21, 2017
Mexican case report of a never-treated Laron syndrome patient evolving to metabolic syndrome, type 2 diabetes, and strokeInma Castilla-Cortazar, Giovana Femat-Roldán, Joel Rodríguez-Rivera, et al.Neuroscience|February 2, 2019
Neurotrophic Factors and Their Receptors Are Altered by the Mere Partial IGF-1 DeficiencyInma Castilla-Cortázar, Ignacio Iturrieta, Mariano García-Magariño, et al.Clinical Case Reports|February 16, 2018
Primary growth hormone insensitivity and psychomotor delayInma Castilla-Cortazar, Julieta Rodríguez De Ita, Gabriel A Aguirre, et al.Plos One|August 15, 2017
Partial IGF-1 deficiency is sufficient to reduce heart contractibility, angiotensin II sensibility, and alter gene expression of structural and functional cardiac proteinsJosé Luis González-Guerra, Inma Castilla-Cortazar, Gabriel A Aguirre, et al.Pageof 2